- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$3.27 BnMarket Estimate, 2026
$3.42 BnMarket Forecast, 2034
$4.86 BnCAGR, 2026–2034
4.9%Middle East and Africa Lung Cancer Surgery Market Size, Growth, Trends & Forecast (2026–2034)
The Middle East and Africa lung cancer surgery market size was valued at USD 3.27 billion in 2025, is estimated to be worth USD 3.42 billion in 2026, and is projected to reach USD 4.86 billion by 2034, registering a compound annual growth rate (CAGR) of 4.9% during the forecast period from 2026 to 2034. Driven by rising pollution levels, an increasing number of cigarette smokers, and a growing geriatric population, the regional market continues to expand steadily.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 3.27 Billion
- 2026 Current Valuation: USD 3.42 Billion
- 2034 Forecast Valuation: USD 4.86 Billion
- Compound Annual Growth Rate (CAGR): 4.9% (2026–2034)
- Fastest-Growing Procedure Segment: Minimally Invasive (projected at the highest CAGR due to early detection awareness and clinical advantages over conventional surgeries)
- Dominant Device Segment: Surgical Instruments (dominating the market driven by shorter device lifespans and widespread adoption)
Core Market Drivers
- Rising Disease Prevalence: Increasing incidence and prevalence of lung cancer across the MEA region.
- Environmental & Lifestyle Factors: Growing pollution levels and rising numbers of cigarette smokers.
- Demographic Shift: A rapidly rising geriatric population more susceptible to pulmonary malignancies.
Primary Market Restraints & Challenges
- High Surgical Costs: High expenses associated with advanced lung cancer surgeries restricting broad patient accessibility.
Middle East and Africa Lung Cancer Surgery Market Segmentation Breakdown
| Segment Category | Sub-Segments Covered |
|---|---|
| By Procedure | Thoracotomy, Minimally Invasive (Fastest-Growing) |
| By Device | Surgical (Clamps, Forceps, Retractors, Staplers, Cutters, Scissors, Elevators, RIB Sheers, Trocars), Monitoring (Cameras, Video Support, Visualizing Systems, Endoscopic Trocars with optical views, Endo Surgical Equipment) |
| By Country | KSA, UAE, Israel, Rest of GCC Countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, Rest of MEA |
Major Industry Players Profiled
Key enterprises shaping the competitive Middle East and Africa lung cancer surgery market include Ethicon US LLC, Intuitive Surgical Inc., AngioDynamics Inc., Olympus Corporation, Accuray Inc., Ackermann Instrumente GmbH, Teleflex Incorporated, KARL STORZ GmbH & Co. KG, Scanlan International Inc., and Trokamed GmbH.
Download Free Sample Report
Middle East and Africa Lung Cancer Surgery Market Size
The Middle East and Africa Lung Cancer Surgery Market size was valued at USD 3.27 billion in 2025 and is anticipated to reach USD 3.42 billion in 2026 from USD 4.86 billion by 2034, growing at a CAGR of 4.9% during the forecast period from 2026 to 2034.
Lung Cancer is Cancer that starts in the lungs or trachea or bronchus. Lung Cancer can be treated by various methods like Chemotherapy, Radiotherapy, Laser therapy, and Surgery. Surgery involves the removal of the infected sections from the lungs. There are many types of Lung Cancer Surgery like Lobectomy, Pneumonectomy, Sleeve Resection, and Segmentectomy.
Rising pollution levels, an increasing number of cigarette smokers, rising incidence and prevalence of Lung Cancer and rising geriatric population are some of the major factors driving the market.
However, high cost of Lung Cancer surgery is restraining the growth of the market.
On the basis of procedure, the Minimally Invasive surgeries are expected to grow at highest CAGR owing to the rising awareness among people for early detection of lung cancer and advantages of Minimally Invasive Surgeries over conventional surgeries.
On the basis of the device, the Surgical Instruments segment is expected to dominate the market owing to the shorter lifespan of devices and wider adoption of these devices.
KEY MARKET PLAYERS
Leading companies in the MEA Lung Cancer Surgery Market include
- Ethicon US LLC
- Intuitive Surgical Inc.
- AngioDynamics Inc.
- Olympus Corporation
- Accuray Inc.
- Ackermann Instrumente GmbH
- Teleflex Incorporated
- KARL STORZ GmbH & Co. KG
- Scanlan International Inc.
- Trokamed GmbH
MARKET SEGMENTATION
This research report on the Middle East and Africa Lung Cancer Surgery Market has been segmented & sub-segmented into the following categories.
By Procedure
- Thoracotomy
- Minimally Invasive
By Device
- Surgical
- Clamps
- Forceps
- Retractors
- Staplers
- Cutters
- Scissors
- Elevators
- RIB Sheers
- Trocars
- Monitoring
- Cameras
- Video Support
- Visualizing Systems
- Endoscopic Trocars with optical views
- Endo Surgical Equipment
By Country
- KSA
- UAE
- Israel
- rest of GCC countries
- South Africa
- Ethiopia
- Kenya
- Egypt
- Sudan
- rest of MEA